Cutaneous leishmaniasis (CL) is a severely neglected tropical disease that has been
significantly increasing in numbers affected over the past decades, with a change in global …

Leishmaniasis is a tropical infectious disease caused by the protozoan Leishmania parasite.
The disease is transmitted by female sand flies and, depending on the infecting parasite …

Leishmaniasis is a disease complex caused by 20 species of protozoan parasites belonging
to the genus Leishmania. In humans, it has two main clinical forms, visceral leishmaniasis …

Abstract Objectives Meglumine antimoniate (MA; Glucantime®), the 80‐year‐old first‐line
systemic treatment for all forms of American tegumentary leishmaniasis (ATL) caused by …

Leishmaniasis is a neglected and old emerging/reemerging disease that has extremely
increased and expanded in the different geographical areas. Cutaneous leishmaniasis (CL) …

Background Cutaneous leishmaniasis (CL) is a neglected tropical disease causing an
estimated 1 million new cases annually. While antimonial compounds are the standard of …

The multifactorial basis of therapeutic response can obscure the relation between
antimicrobial drug susceptibility and clinical outcome. To discern the relationship between …

Background Cutaneous leishmaniasis (CL) in Ethiopia, caused by Leishmania aethiopica, is
often severe and hard to treat compared to CL caused by other species elsewhere …

Background Treatment guidance for children and older adult patients affected by cutaneous
leishmaniasis (CL) is unclear due to limited representation of these groups in clinical trials …

Leishmaniasis is a disease caused by protozoa of the genus Leishmania. Treatment options
are limited, and there are frequent cases of treatment failure and clinical relapse. To …